report guidanc tweak deal-tim
report adj ep handili beat opco/street
estim despit concern around flu adj ep exclud
amort acquisition-rel expens otherwis result beat
compani expect due oper due delay
financ fide due delay assumpt around deal reduc
ep guidanc although reduc
ep estim maintain ep
estim price target long-term contribut expect
deal remain unchang
recap result handili beat expect driven out-performance
hbr vs opco/street despit concern around
impact flu partial off-set sg vs opco/street
earlier start exchang period tend gener higher
sg lower hbr
fide appear back track follow late-march deal
new york compani secur approv two three state
regul expect attorney gener approv near futur
compani appear confid new assum close
juli discount possibl beat timelin
guidanc expect impact shift deal-clos
vs april financ may march off-set
out-performance therefor lower ep guidanc
although number could prove conserv given
deal/financ timing-assumpt manag expect
similar dip due open enrol spend
long-term fide opportun promis expect achiev
first-year synergy-target reiter long-
term target driven target medical-manag cost increas
invest fraud/abus payment integr etc estim
upsid deal effect full-year drive ampl
growth along increas synergi benefit
conclus overal quarter strong see chang
long-term outlook stock due guidanc tweak result
maintain outperform rate would continu long-term buyer
care program relat servic
beneficiari medicaid
analyst certif import disclosur see disclosur
acquisit integr go expect synergi achiev
enrol trend continu track line expect
demand medicaid manag care continu grow state
increasingli outsourc tradit medicaid higher
acut popul manag care follow net
acquisit acquisit fide
benefit multi-year synergi opportun expand
medicar advantag presenc last view margin
opportun signific compani larg new-memb
popul like take time matur legaci margin
result believ continu boast strong revenu
earn growth prospect year come
negoti congress legisl
 integr go poorli synergi recogn
meaning uptick util trend
deterior exchang busi
price target base combin two methodolog dcf valuat base beta
termin growth rate wacc estim ebitda p/e-bas valuat
repres ep estim target price-to-earnings multipl conserv discount five-year histor
averag medicaid name
state budgetari pressur state often cut rate deal budgetari pressur risk need integr includ
larg hnt deal state exposur tx fl ga account enrol growth rapid growth expos
newer less certain contract
servic
servic ratio
depreci amort
invest incom
incom tax
net incom report
dilut ep report
compani report oppenheim co
servic
servic ratio
gener administr expens
premium tax insur fee
depreci amort
net incom report
incom tax
invest incom
report
premium servic revenu
sell gener administr
depreci amort
invest incom
incom tax
net incom report
